Price$6.96+0.43 (+6.58%)
2026-03-042026-06-05
News · 26 weeks11-100%
2025-12-142026-06-07
Mix890d
- SEC Filings6(75%)
- Other2(25%)
Latest news
25 items- SECUnited-Guardian Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- SECSEC Form 10-Q filed by United-Guardian Inc.10-Q - UNITED GUARDIAN INC (0000101295) (Filer)
- SECUnited-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Reports First Quarter ResultsHAUPPAUGE, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the first quarter of 2026. First quarter sales increased from $2,481,127 in 2025 to $2,872,222 in 2026, with net income increasing from $560,895 ($0.12 per share) to $818,902 ($0.18 per share). Donna Vigilante, President of United-Guardian, stated, "I am happy to report that sales and earnings increased in the first quarter of 2026 compared with the first quarter of 2025. Our financial performance was primarily driven by increased sales of both our pharmaceuticals and cosmetic ingredients. Pharmaceutical sales rose by 24% in the first quarter of 2026, driven primar
- SECSEC Form DEF 14A filed by United-Guardian Inc.DEF 14A - UNITED GUARDIAN INC (0000101295) (Filer)
- SECSEC Form 10-K filed by United-Guardian Inc.10-K - UNITED GUARDIAN INC (0000101295) (Filer)
- SECUnited-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Reports 2025 Financial ResultsHAUPPAUGE, N.Y., March 27, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported that net sales and net income for FY 2025 decreased compared to FY 2024. Net sales for the year decreased by 13% from $12,181,971 in 2024 to $10,545,468 in 2025, generating net income of $3,250,875 ($0.71 per share) in 2024 compared to $2,105,738 ($0.46 per share) in 2025. Donna Vigilante, President of United-Guardian, stated, "Our financial performance in 2025 was primarily impacted by the decrease in sales of our cosmetic ingredients. One of the issues we faced was excess inventory held by our largest cosmetic ingredient distributor, Ashland Specialty Ingredients ("ASI"). The inventory oversto
- SECUnited-Guardian Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Declares Cash DividendHAUPPAUGE, N.Y., Jan. 29, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on January 26, 2026, declared a cash dividend of $0.25 per share, to be paid on February 17, 2026, to all stockholders of record as of the close of business on February 9, 2026. This will be the 31st consecutive year the company has paid a dividend. Donna Vigilante, President of United-Guardian, stated, "The company's Board of Directors has decided to once again distribute a dividend of $0.25 per share to our stockholders, which is consistent with the dividend we paid last July. Our dividend strategy balances earnings, growth initiative
- INSIDERDirector Globus Kenneth H gifted 7,480 shares (SEC Form 4)4 - UNITED GUARDIAN INC (0000101295) (Issuer)
- SECSEC Form 10-Q filed by United-Guardian Inc.10-Q - UNITED GUARDIAN INC (0000101295) (Filer)
- SECUnited-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Reports Third Quarter EarningsHAUPPAUGE, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the third quarter and the first nine months of 2025. Sales for the nine-month period ended September 30th decreased from $9,705,262 in 2024 to $7,583,613 in 2025 and net income decreased from $2,747,151 ($0.60 per share) to $1,456,162 ($0.32 per share). Third quarter sales decreased from $3,060,113 in 2024 to $2,264,261 in 2025 and net income decreased from $865,484 ($0.19 per share) to $268,441 ($0.06 per share). Donna Vigilante, President of United-Guardian, stated, "While sales of our pharmaceutical and medical products both increased during the first nine-mont
- SECSEC Form 10-Q filed by United-Guardian Inc.10-Q - UNITED GUARDIAN INC (0000101295) (Filer)
- SECUnited-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Reports Second Quarter ResultsHAUPPAUGE, N.Y., Aug. 08, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2025. Second quarter net sales decreased from $3,390,205 in 2024 to $2,838,225 in 2025, with net income decreasing from $956,225 ($0.21 per share) to $626,826 ($0.14 per share). As compared with the first quarter of 2025, the second quarter net sales increased by 14% and net income increased by 12%. Net sales for the six-month period ended June 30th decreased from $6,645,149 in 2024 to $5,319,352 in 2025 and net income decreased from $1,881,667 ($0.41 per share) to $1,187,721 ($0.26 per share). Donna Vigilante, President of Uni
- SECUnited-Guardian Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Declares Cash DividendHAUPPAUGE, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on July 11, 2025, declared a cash dividend of $0.25 per share, to be paid on August 1, 2025, to all stockholders of record as of the close of business on July 25, 2025. This will be the 30th consecutive year that the company has paid a dividend. Donna Vigilante, President of United-Guardian, stated, "I am pleased to report that the company's Board of Directors has decided to distribute a dividend of $0.25 per share to our stockholders. As part of the Board's decision-making process it took into account the need for capital to fund some
- SECUnited-Guardian Inc. filed SEC Form 8-K: Leadership Update, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Appoints New Board MemberHAUPPAUGE, N.Y., May 21, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG), a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness ingredients, announced today that the company's Board of Directors has appointed Donna Vigilante, the company's President, as its newest director. Ms. Vigilante has been with the company for more than 20 years. She has a Bachelor of Science degree in biochemistry with a minor in business from Stony Brook University. During her tenure with the company she has held several positions, including Vice President and Manager of the company's R&D and microbiology departments. As R&D Manager she was responsible for overs
- SECUnited-Guardian Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- SECSEC Form 10-Q filed by United-Guardian Inc.10-Q - UNITED GUARDIAN INC (0000101295) (Filer)
- SECUnited-Guardian Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - UNITED GUARDIAN INC (0000101295) (Filer)
- PRUnited-Guardian Reports First Quarter ResultsHAUPPAUGE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the first quarter of 2025. First quarter sales decreased from $3,254,944 in 2024 to $2,481,127 in 2025, with net income decreasing from $925,442 ($0.20 per share) to $560,895 ($0.12 per share). Donna Vigilante, President of United-Guardian, stated, "We are experiencing a slow start to 2025 compared to the beginning of 2024. While we saw positive performance from our medical lubricant and pharmaceutical businesses, the main reason for the decrease in sales and earnings was due to a decrease in our cosmetic ingredient business. Medical lubricant and pharmaceutica
UG FAQ
5 questionsWhat does United-Guardian Inc. do?
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products in the United States and internationally. It offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders...Where does UG stock trade?
United-Guardian Inc. (UG) is listed on NASDAQ.What sector and industry is UG in?
United-Guardian Inc. operates in the Consumer Discretionary sector, Package Goods/Cosmetics industry.What companies are similar to UG?
Notable peers in the same industry include PG (Procter & Gamble Company), UL (Unilever PLC), ECL (Ecolab Inc.), CL (Colgate-Palmolive Company), HLN (Haleon plc). Compare UG side-by-side with any of them on Quantisnow.How can I track UG on Quantisnow?
Quantisnow aggregates United-Guardian Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow UG to receive live email and push alerts on every new disclosure.